PT  - JOURNAL ARTICLE
AU  - Eken, Aykut
AU  - Nassehi, Farhad
AU  - Eroğul, Osman
TI  - Diagnostic Machine Learning Applications on Clinical Populations using Functional Near Infrared Spectroscopy: A Review
AID  - 10.1101/2023.02.07.23285578
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.02.07.23285578
4099  - http://medrxiv.org/content/early/2023/09/25/2023.02.07.23285578.short
4100  - http://medrxiv.org/content/early/2023/09/25/2023.02.07.23285578.full
AB  - Functional near-infrared spectroscopy (fNIRS) and its interaction with machine learning (ML) is a popular research topic for the diagnostic classification of clinical disorders due to the lack of robust and objective biomarkers. This review provides an overview of research on psychiatric diseases by using fNIRS and ML. Article search was carried out and 45 studies were evaluated by considering their sample sizes, used features, ML methodology, and reported accuracy. To our best knowledge, this is the first review that reports diagnostic ML applications using fNIRS. We found that there has been an increasing trend to perform ML applications on fNIRS-based biomarker research since 2010. The most studied populations are schizophrenia (n=12), attention deficit and hyperactivity disorder (n=7), and autism spectrum disorder (n=6) are the most studied populations. There is a significant negative correlation between sample size (>20) and accuracy values. Support vector machine (SVM) and deep learning (DL) approaches were the most popular classifier approaches (SVM = 20) (DL = 10). Eight of these studies recruited a number of participants more than 100 for classification. Change in oxy-hemoglobin (ΔHbO) based features were used more than change in deoxy-hemoglobin-based ones and the most popular ΔHbO-based features were mean ΔHbO (n=11) and ΔHbO-based functional connections (n=11). Using ML on fNIRS data might be a promising approach to reveal specific biomarkers for diagnostic classification.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.No new data were created or analyzed in this study